Based on the provided financial report articles, the title of the article is: "West Enclave Merger Corp. Reports Financial Results for the Quarter Ended March 31, 2026" Note that this is a quarterly report (Form 10-Q) filed with the Securities and Exchange Commission (SEC) by West Enclave Merger Corp., a company incorporated in the Cayman Islands.
West Enclave Merger Corp. filed its Form 10-Q for the quarter ended March 31, 2026. The company reported a significant increase in its cash and cash equivalents, from $23.4 million as of December 31, 2025 to $43.4 million as of March 31, 2026, primarily due to the issuance of 5,000,000 units in a private placement and the exercise of the over-allotment option by the underwriters. The company also reported a net loss of $1.4 million for the quarter, primarily due to expenses related to the business combination with Sponsor and the issuance of the units. As of March 31, 2026, the company had a total of 10,000,000 ordinary shares outstanding, with an aggregate value of $100 million. The company’s financial statements are presented in US dollars, and the company is incorporated in the Cayman Islands.
Overview
We are a blank check company formed in the Cayman Islands on December 9, 2025 with the purpose of merging with or acquiring a business (a “Business Combination”). We raised $100 million through an initial public offering (IPO) on May 1, 2026, and an additional $15 million through the exercise of the over-allotment option, for a total of $116.15 million held in a trust account. Our goal is to use these funds to identify and complete a Business Combination.
Financial Performance
As a newly formed company, we have not engaged in any operations or generated any revenue as of March 31, 2026. Our only activities have been organizational tasks and preparing for the IPO. We incurred $40,398 in general and administrative costs during the three months ended March 31, 2026, resulting in a net loss for the period.
Liquidity and Capital Resources
Prior to the IPO, our only source of funding was an initial purchase of shares by our sponsor and loans from the sponsor. After the IPO and exercise of the over-allotment option, we have $116.15 million held in a trust account, which we intend to use to complete a Business Combination.
We may need to obtain additional financing to cover the costs of identifying and evaluating potential target businesses, as well as completing a Business Combination. The sponsor or our officers and directors may provide loans of up to $1.5 million, which could be convertible into private placement units of the post-Business Combination entity.
We do not believe we will need to raise additional funds to meet our current expenditures, but additional financing may be required depending on the actual costs involved.
Strengths and Weaknesses
A key strength is the significant capital we raised through the IPO and over-allotment, providing us ample resources to pursue a Business Combination. However, as a newly formed company with no operations, we face the challenge of identifying and evaluating suitable target businesses, as well as negotiating and completing a successful transaction.
Outlook
Our focus in the near-term will be on identifying and evaluating potential target businesses for a Business Combination. We cannot guarantee that we will be able to complete a transaction, as this process involves significant uncertainty. If we are unable to find an appropriate target and complete a Business Combination, we may be forced to liquidate and return the funds to our shareholders.
